HK19395A - Film-coated solid dosage form of anti-migraine drug - Google Patents
Film-coated solid dosage form of anti-migraine drugInfo
- Publication number
- HK19395A HK19395A HK19395A HK19395A HK19395A HK 19395 A HK19395 A HK 19395A HK 19395 A HK19395 A HK 19395A HK 19395 A HK19395 A HK 19395A HK 19395 A HK19395 A HK 19395A
- Authority
- HK
- Hong Kong
- Prior art keywords
- film
- solid dosage
- coated solid
- dosage form
- migraine drug
- Prior art date
Links
- 239000007909 solid dosage form Substances 0.000 title abstract 3
- 229940124433 antimigraine drug Drugs 0.000 title 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Waveguide Aerials (AREA)
- Non-Reversible Transmitting Devices (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Indole Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919104890A GB9104890D0 (en) | 1991-03-08 | 1991-03-08 | Compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
HK19395A true HK19395A (en) | 1995-02-17 |
Family
ID=42342461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK19395A HK19395A (en) | 1991-03-08 | 1995-02-09 | Film-coated solid dosage form of anti-migraine drug |
Country Status (29)
Country | Link |
---|---|
US (4) | US5863559A (xx) |
EP (1) | EP0503440B1 (xx) |
JP (1) | JP2986546B2 (xx) |
KR (1) | KR100202042B1 (xx) |
AT (1) | ATE165973T1 (xx) |
AU (1) | AU663303B2 (xx) |
BE (1) | BE1005086A5 (xx) |
CA (1) | CA2105180C (xx) |
CH (1) | CH684242A5 (xx) |
CY (1) | CY2011A (xx) |
CZ (1) | CZ282352B6 (xx) |
DE (1) | DE69225421T2 (xx) |
DK (1) | DK0503440T3 (xx) |
ES (1) | ES2117015T3 (xx) |
FR (1) | FR2673538B1 (xx) |
GB (2) | GB9104890D0 (xx) |
GE (1) | GEP20012549B (xx) |
HK (1) | HK19395A (xx) |
IE (1) | IE920726A1 (xx) |
IL (1) | IL101162A (xx) |
IT (1) | IT1271495B (xx) |
MX (1) | MX9200992A (xx) |
NL (1) | NL9200423A (xx) |
NZ (1) | NZ241873A (xx) |
OA (1) | OA09812A (xx) |
RU (1) | RU2098093C1 (xx) |
SG (1) | SG169294G (xx) |
WO (1) | WO1992015295A1 (xx) |
ZA (1) | ZA921690B (xx) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9104890D0 (en) * | 1991-03-08 | 1991-04-24 | Glaxo Group Ltd | Compositions |
ES2106818T3 (es) * | 1991-10-30 | 1997-11-16 | Glaxo Group Ltd | Composicion multicapa que contiene antagonistas de histamina o secotina. |
DE4314976C1 (de) * | 1993-05-06 | 1994-10-06 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung |
US8022095B2 (en) * | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
US6066092A (en) * | 1997-11-06 | 2000-05-23 | Cady; Roger K. | Preemptive prophylaxis of migraine device and method |
GB9924717D0 (en) * | 1999-10-19 | 1999-12-22 | Glaxo Group Ltd | Diagnostic |
AT500063A1 (de) | 1999-11-23 | 2005-10-15 | Sandoz Ag | Beschichtete tablettenkerne |
US20020064555A1 (en) * | 2000-09-29 | 2002-05-30 | Dan Cullen | Proton pump inhibitor formulation |
US20030070584A1 (en) * | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
AU4061702A (en) * | 2001-05-15 | 2003-04-03 | Mcneil-Ppc, Inc. | Dip coating compositions containing starch or dextrin |
US8329734B2 (en) | 2009-07-27 | 2012-12-11 | Afgin Pharma Llc | Topical therapy for migraine |
ES2312585T3 (es) * | 2001-06-05 | 2009-03-01 | Ronald Aung-Din | Terapia contra la migraña por via topica. |
US8309118B2 (en) * | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
GB0129117D0 (en) * | 2001-12-05 | 2002-01-23 | Glaxo Group Ltd | Pharmaceutical composition |
US20040052843A1 (en) * | 2001-12-24 | 2004-03-18 | Lerner E. Itzhak | Controlled release dosage forms |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
CN1681493A (zh) * | 2002-07-19 | 2005-10-12 | 兰贝克赛实验室有限公司 | 掩味舒马曲坦片剂及其制备方法 |
US7429619B2 (en) * | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
US20040068000A1 (en) * | 2002-10-02 | 2004-04-08 | Mintong Guo | Compression coated tablets |
US7332183B2 (en) * | 2002-12-26 | 2008-02-19 | Pozen Inc. | Multilayer dosage forms containing NSAIDs and triptans |
US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
WO2004076403A1 (en) * | 2003-02-24 | 2004-09-10 | Transform Pharmaceuticals, Inc. | Sumatriptan crystalline forms, pharmaceutical compositions and methods |
WO2004110492A2 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and nsaids |
EP1644004A4 (en) * | 2003-06-20 | 2010-10-06 | Ronald Aung-Din | LOCAL THERAPY FOR THE TREATMENT OF MIGRAINS, MUSCLE CLARIFICATIONS, MUSCLE SPASMS, SPASTICITY AND RELATED CONDITIONS |
GB2407498B (en) * | 2003-10-30 | 2008-06-11 | Cipla Ltd | Oral formulations for 5-HT receptor agonists with reduced degradation of active ingredient |
GB0400452D0 (en) * | 2004-01-09 | 2004-02-11 | Norton Healthcare Ltd | A pharmaceutical composition |
GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
US8216610B2 (en) * | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
US20080287456A1 (en) * | 2004-05-28 | 2008-11-20 | Imaginot Pty Ltd | Oral Therapeutic Compound Delivery System |
WO2005123043A2 (en) * | 2004-06-10 | 2005-12-29 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
AU2006249577A1 (en) | 2005-05-20 | 2006-11-30 | Janssen Pharmaceutica N.V. | Process for preparation of sulfamide derivatives |
JP2009517346A (ja) * | 2005-11-28 | 2009-04-30 | イメイジノット ピーティーワイ エルティーディー | 治療用化合物の経口送達系 |
US20070166336A1 (en) * | 2005-12-13 | 2007-07-19 | David Delmarre | Stable and palatable oral liquid sumatriptan compositions |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US8492431B2 (en) | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
EP2026790A2 (en) | 2006-05-19 | 2009-02-25 | Janssen Pharmaceutica, N.V. | Co-therapy for the treatment of epilepsy and related disorders |
EP2813144A1 (en) | 2006-10-09 | 2014-12-17 | Charleston Laboratories, Inc. | Analgesic compositions comprising an antihistamine |
JP2010507585A (ja) | 2006-10-19 | 2010-03-11 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 置換インドール |
WO2009089494A2 (en) | 2008-01-09 | 2009-07-16 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
US20090252791A1 (en) * | 2008-04-02 | 2009-10-08 | Venkata Nookaraju Sreedharala | Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug |
EP2306998A4 (en) * | 2008-06-20 | 2011-06-15 | Alphapharm Pty Ltd | PHARMACEUTICAL FORMULATION |
BRPI0915890A2 (pt) | 2008-06-23 | 2015-11-03 | Janssen Pharmaceutica Nv | forma cristalina de (2s)-(-)-n-(6-cloro-2,3-di-hidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida |
WO2010005507A1 (en) * | 2008-06-30 | 2010-01-14 | Afgin Pharma, Llc | Topical regional neuro-affective therapy |
US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
EP2451274B1 (en) | 2009-07-08 | 2017-10-04 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
EP2480197B1 (en) | 2009-09-25 | 2015-11-11 | Dr. Reddy's Laboratories Ltd. | Formulations comprising triptan compounds |
US11337962B2 (en) | 2009-09-25 | 2022-05-24 | Upsher-Smith Laboratories, Llc | Formulations comprising triptan compounds |
US10383816B2 (en) | 2015-03-02 | 2019-08-20 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoid combination products |
BR112017018944A2 (pt) | 2015-03-02 | 2018-05-15 | Afgin Pharma Llc | método de tratamento de um estado ou condição de doença em humanos com um medicamento carbinóide, e, método de tratamento de um estado ou condição de doença em um mamífero diferente de um humano com medicamento(s) carbinóide(s) |
WO2017152130A1 (en) | 2016-03-04 | 2017-09-08 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
US20180049994A1 (en) | 2016-08-16 | 2018-02-22 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with caryophyllene |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79215B (xx) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
GB8928208D0 (en) * | 1989-12-13 | 1990-02-14 | Glaxo Group Ltd | Medicaments |
GB9104890D0 (en) * | 1991-03-08 | 1991-04-24 | Glaxo Group Ltd | Compositions |
-
1991
- 1991-03-08 GB GB919104890A patent/GB9104890D0/en active Pending
-
1992
- 1992-03-02 US US08/381,422 patent/US5863559A/en not_active Expired - Fee Related
- 1992-03-02 JP JP4504967A patent/JP2986546B2/ja not_active Expired - Fee Related
- 1992-03-02 AU AU13264/92A patent/AU663303B2/en not_active Ceased
- 1992-03-02 ES ES92103592T patent/ES2117015T3/es not_active Expired - Lifetime
- 1992-03-02 CZ CS931849A patent/CZ282352B6/cs not_active IP Right Cessation
- 1992-03-02 DK DK92103592T patent/DK0503440T3/da active
- 1992-03-02 AT AT92103592T patent/ATE165973T1/de not_active IP Right Cessation
- 1992-03-02 KR KR1019930702672A patent/KR100202042B1/ko not_active IP Right Cessation
- 1992-03-02 EP EP92103592A patent/EP0503440B1/en not_active Expired - Lifetime
- 1992-03-02 GE GEAP19922601A patent/GEP20012549B/en unknown
- 1992-03-02 RU RU9393057724A patent/RU2098093C1/ru not_active IP Right Cessation
- 1992-03-02 WO PCT/EP1992/000460 patent/WO1992015295A1/en active IP Right Grant
- 1992-03-02 CA CA002105180A patent/CA2105180C/en not_active Expired - Fee Related
- 1992-03-02 DE DE69225421T patent/DE69225421T2/de not_active Expired - Fee Related
- 1992-03-05 GB GB9204761A patent/GB2254784B/en not_active Expired - Fee Related
- 1992-03-06 BE BE9200230A patent/BE1005086A5/fr not_active IP Right Cessation
- 1992-03-06 IE IE072692A patent/IE920726A1/en not_active IP Right Cessation
- 1992-03-06 FR FR9202709A patent/FR2673538B1/fr not_active Expired - Fee Related
- 1992-03-06 CH CH727/92A patent/CH684242A5/fr not_active IP Right Cessation
- 1992-03-06 NZ NZ241873A patent/NZ241873A/xx unknown
- 1992-03-06 IL IL101162A patent/IL101162A/xx unknown
- 1992-03-06 MX MX9200992A patent/MX9200992A/es not_active IP Right Cessation
- 1992-03-06 NL NL9200423A patent/NL9200423A/nl active Search and Examination
- 1992-03-06 IT ITRM920155A patent/IT1271495B/it active IP Right Grant
- 1992-03-06 ZA ZA921690A patent/ZA921690B/xx unknown
-
1993
- 1993-08-19 OA OA60402A patent/OA09812A/en unknown
-
1994
- 1994-12-01 SG SG169294A patent/SG169294G/en unknown
-
1995
- 1995-02-09 HK HK19395A patent/HK19395A/xx not_active IP Right Cessation
-
1998
- 1998-02-20 CY CY201198A patent/CY2011A/xx unknown
- 1998-07-24 US US09/121,530 patent/US6020001A/en not_active Expired - Fee Related
-
2000
- 2000-01-13 US US09/481,933 patent/US6368627B1/en not_active Expired - Fee Related
-
2002
- 2002-02-28 US US10/084,683 patent/US20020197318A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2254784B (en) | Film-coated solid dosage form of anti-migraine drug | |
RU93057724A (ru) | Фармацевтическая композиция, способ ее получения и способ лечения | |
AP1818A (en) | Urea-compounds active as vanilloid receptor antagonists for the treatment of pain | |
IL209703A0 (en) | Controlled release hydrocodone formulations | |
GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
ATE130758T1 (de) | Arzneimittel zur intranasalen verabreichung, die ketorolac r enthalten. | |
CA2098302A1 (en) | Medicaments | |
GEP20043324B (en) | Purine Derivatives | |
SE9901573D0 (sv) | New compounds | |
WO1999033450A3 (en) | Pharmaceutical composition containing sibutramine and orlistat | |
GR3015014T3 (en) | Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts. | |
GB9108629D0 (en) | Heterocyclic pharmaceutical compounds,preparation and use | |
BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
AP9901474A0 (en) | Pharmaceutical composition for treating viral diseases. | |
NZ303993A (en) | Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders | |
MY133438A (en) | Morpholinobenzamide salts | |
WO2001000187A3 (en) | Pharmaceutical composition containing sibutramine and a lipase inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20050305 |